Your June Update for Aurora Cannabis’s Price Target and Ratings – Market Realist

0
35
Your June Update for Aurora Cannabis’s Price Target and Ratings – Market Realist

Aurora Cannabis ratings

Aurora Cannabis (ACB) has been on a downtrend since March this year, and the decline accelerated after it released its earnings on May 14. The company has lost almost 12% since then, while the Horizons Marijuana Life Sciences ETF (HMMJ) has lost about 6%. In contrast, Tilray (TLRY), which also reported its earnings on the same day, has risen by about 5%. Let’s look at the company’s ratings and price target change over the past month.

Your June Update for Aurora Cannabis’s Price Target and Ratings

Ratings

The current consensus rating from 14 analysts for Aurora Cannabis was a “buy,” which remained unchanged from the last month. Of the 14 analysts, four maintained a “strong buy” on the stock while six maintained a “buy” on the company in the current month. However, the number of analysts recommending a “hold” rose to three from two while one continued to have a “sell” rating on the stock. Aurora’s peer Tilray and Cronos Group (CRON) both had a “hold” recommendation each in the current month.

Price target

Month-over-month, Aurora Cannabis’s consensus price target was slightly lower at 14.3 Canadian dollars from 14.7 Canadian dollars a month ago. However, based on the closing of 9.7 Canadian dollars on June 21, the current price target would still entail an upside of about 48% if the current price were to converge to this price target. Read HEXO’s Target Price Gets an Upgrade in May.

LEAVE A REPLY

Please enter your comment!
Please enter your name here